Frontiers in Psychiatry,
Journal Year:
2020,
Volume and Issue:
11
Published: Sept. 23, 2020
Legalization
and
commercial
sale
of
non-medical
cannabis
has
led
to
increasing
diversity
potency
products.
Some
the
American
states
that
were
first
legalize
have
seen
rises
in
acute
harms
associated
with
use,
e.g.
Colorado
increases
emergency
department
visits
for
cannabis-related
psychological
distress
severe
vomiting
(hyperemesis),
as
well
a
number
high-profile
deaths
related
ingestion
high
doses
edibles.
Over-ingestion
is
multiple
factors,
including
products
levels
THC
consumers'
confusion
regarding
labelling
products,
which
disproportionately
impact
new
or
inexperienced
users.
Based
on
our
review
literature,
we
propose
three
approaches
minimizing
harms:
early
restriction
edibles
high-potency
products;
clear
consistent
communicates
dose/serving
size
health
risks;
implementation
robust
data
collection
frameworks
monitor
harms,
broken
down
by
product
type
(e.g.
dose,
potency,
route
administration)
consumer
characteristics
age,
sex,
gender,
ethnicity).
Ongoing
monitoring
jurisdictions
existing
legal
laws
will
be
vital
understanding
legalization
maximizing
public
benefits.
Journal of the International Neuropsychological Society,
Journal Year:
2017,
Volume and Issue:
23(9-10), P. 893 - 902
Published: Oct. 1, 2017
Abstract
Cannabis
use
has
been
linked
to
impairments
in
neuropsychological
functioning
across
a
large
and
continually
expanding
body
of
research.
Yet
insight
into
underlying
causal
relations
remains
limited
due
the
historically
cross-sectional
nature
studies
this
area.
Recently,
however,
have
begun
more
informative
design
strategies
delineate
these
associations.
The
aim
article
is
provide
critical
evaluation
review
research
that
uses
longitudinal
designs
examine
link
between
cannabis
functioning.
In
summarizing
primary
findings
studies,
suggests
leads
decline.
However,
most
associations
were
modest,
present
only
for
group
with
heaviest
use,
often
attenuated
(or
no
longer
significant)
after
controlling
potential
confounding
variables.
Future
data
before
initiation
along
careful
measurement
control
“shared
risk
factors”
poorer
outcomes,
are
needed
better
understand
who,
under
what
conditions,
vulnerable
cannabis-associated
(
JINS
,
2017,
23
893–902)
Prevention Science,
Journal Year:
2018,
Volume and Issue:
20(2), P. 257 - 269
Published: April 27, 2018
Adolescence
and
young
adulthood
is
a
critical
stage
when
the
economic
foundations
for
life-long
health
are
established.
To
date,
there
little
consensus
as
to
whether
marijuana
use
associated
with
poor
educational
occupational
success
in
adulthood.
We
investigated
associations
between
trajectories
of
from
ages
15
28
multiple
indicators
well-being
including
achievement
levels
(i.e.,
attainment
prestige),
work
characteristics
full
vs
part-time
employment,
hours
worked,
annual
income),
financial
strain
debt,
trouble
paying
necessities,
delaying
medical
attention),
perceived
workplace
stress.
Data
were
Victoria
Healthy
Youth
Survey,
10-year
prospective
study
randomly
recruited
community
sample
662
youth
(48%
male;
Mage
=
15.5),
followed
biennially
six
assessments.
Models
adjusted
baseline
age,
sex,
SES,
high
school
grades,
heavy
drinking,
smoking,
internalizing
oppositional
defiant
disorder
symptoms.
Chronic
users
(our
highest
risk
class)
reported
lower
attainment,
prestige,
income,
greater
more
difficulty
necessities
compared
abstainers.
Similarly,
increasers
also
income.
Decreasers,
who
had
early
but
quit
over
time,
showed
resilience
well-being,
performing
similar
Groups
did
not
differ
on
employment
status
or
The
findings
indicate
that
onset
persistent
increasingly
frequent
transition
adolescent
risks
achieving
success,
subsequently
health,
Frontiers in Psychiatry,
Journal Year:
2020,
Volume and Issue:
11
Published: Sept. 23, 2020
Legalization
and
commercial
sale
of
non-medical
cannabis
has
led
to
increasing
diversity
potency
products.
Some
the
American
states
that
were
first
legalize
have
seen
rises
in
acute
harms
associated
with
use,
e.g.
Colorado
increases
emergency
department
visits
for
cannabis-related
psychological
distress
severe
vomiting
(hyperemesis),
as
well
a
number
high-profile
deaths
related
ingestion
high
doses
edibles.
Over-ingestion
is
multiple
factors,
including
products
levels
THC
consumers'
confusion
regarding
labelling
products,
which
disproportionately
impact
new
or
inexperienced
users.
Based
on
our
review
literature,
we
propose
three
approaches
minimizing
harms:
early
restriction
edibles
high-potency
products;
clear
consistent
communicates
dose/serving
size
health
risks;
implementation
robust
data
collection
frameworks
monitor
harms,
broken
down
by
product
type
(e.g.
dose,
potency,
route
administration)
consumer
characteristics
age,
sex,
gender,
ethnicity).
Ongoing
monitoring
jurisdictions
existing
legal
laws
will
be
vital
understanding
legalization
maximizing
public
benefits.
